×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRL – charles river laboratories international, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
10:02 am
crl
Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects [Yahoo! Finance]
Low
Report
Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects [Yahoo! Finance]
12/19
08:07 am
crl
Animal Model Market Size Projected to Reach USD 4.6 Billion by 2032 – Research by SNS Insider [Yahoo! Finance]
Low
Report
Animal Model Market Size Projected to Reach USD 4.6 Billion by 2032 – Research by SNS Insider [Yahoo! Finance]
12/13
11:16 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Bank of America Co. from $220.00 to $210.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Bank of America Co. from $220.00 to $210.00. They now have a "neutral" rating on the stock.
12/11
07:40 am
crl
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033 [Yahoo! Finance]
Low
Report
Preclinical CRO Industry Assessment: Growth Opportunities and Strategies to 2033 [Yahoo! Finance]
12/10
11:08 am
crl
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 [Yahoo! Finance]
Low
Report
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 [Yahoo! Finance]
12/6
01:00 pm
crl
Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? [Yahoo! Finance]
12/5
05:41 pm
crl
Clinical Trials Market in the US to grow by USD 5 Billion from 2024-2028, driven by more drug trials, with AI redefining market trends - Technavio [Yahoo! Finance]
Low
Report
Clinical Trials Market in the US to grow by USD 5 Billion from 2024-2028, driven by more drug trials, with AI redefining market trends - Technavio [Yahoo! Finance]
12/5
08:10 am
crl
Charles River Introduces Global Biotech Incubator Program [Yahoo! Finance]
Medium
Report
Charles River Introduces Global Biotech Incubator Program [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
11.6%
charles river laboratories international, inc.
8/7/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
-12.6%
charles river laboratories international, inc.
5/9/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
-3.3%
charles river laboratories international, inc.
2/14/2024
07:00 am
crl
charles river laboratories international, inc.
BEAT
Report
11.4%
charles river laboratories international, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/13
04:43 pm
crl
Form 8-K CHARLES RIVER LABORATORI For: Dec 13
Low
Report
Form 8-K CHARLES RIVER LABORATORI For: Dec 13
11/12
04:41 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 08 Filed by: FOSTER JAMES C
Medium
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 08 Filed by: FOSTER JAMES C
11/12
04:38 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 06 Filed by: WALLMAN RICHARD F
Medium
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 06 Filed by: WALLMAN RICHARD F
11/8
06:22 pm
crl
Form 4 CHARLES RIVER LABORATORI For: Nov 07 Filed by: Barbo William D
Low
Report
Form 4 CHARLES RIVER LABORATORI For: Nov 07 Filed by: Barbo William D
11/8
05:35 pm
crl
Form SC 13G/A CHARLES RIVER LABORATORI Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A CHARLES RIVER LABORATORI Filed by: BlackRock, Inc.
11/8
10:53 am
crl
Form SC 13G CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
04:25 pm
crl
Form 144 CHARLES RIVER LABORATORI Filed by: WALLMAN RICHARD F
Low
Report
Form 144 CHARLES RIVER LABORATORI Filed by: WALLMAN RICHARD F
11/6
09:17 am
crl
Form 10-Q CHARLES RIVER LABORATORI For: Sep 28
Low
Report
Form 10-Q CHARLES RIVER LABORATORI For: Sep 28
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/11
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance
11.8%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
TOP News Decliners
3/19
Doctor says he's 3-4 weeks from developing treatment to 'neutralize' coronavirus [FOX News]
-18.6%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: